rs121909670
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PM5PP3PP5_Very_Strong
The NM_004960.4(FUS):c.1561C>T(p.Arg521Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,608,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R521G) has been classified as Pathogenic.
Frequency
Consequence
NM_004960.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FUS | NM_004960.4 | c.1561C>T | p.Arg521Cys | missense_variant | 15/15 | ENST00000254108.12 | NP_004951.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FUS | ENST00000254108.12 | c.1561C>T | p.Arg521Cys | missense_variant | 15/15 | 1 | NM_004960.4 | ENSP00000254108 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000136 AC: 2AN: 147028Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251332Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135838
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461560Hom.: 0 Cov.: 36 AF XY: 0.00000138 AC XY: 1AN XY: 727096
GnomAD4 genome AF: 0.0000136 AC: 2AN: 147028Hom.: 0 Cov.: 31 AF XY: 0.0000140 AC XY: 1AN XY: 71278
ClinVar
Submissions by phenotype
not provided Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Apr 03, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | FUS: PP1:Strong, PM1, PM5, PS2:Moderate, PS3:Moderate, PS4:Moderate - |
Pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
FUS-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 05, 2024 | The FUS c.1561C>T variant is predicted to result in the amino acid substitution p.Arg521Cys. This variant has been reported to be causative for amyotrophic lateral sclerosis (ALS, Kwiatkowski et al. 2009. PubMed ID: 19251627; Vance et al. 2009. PubMed ID: 19251628; Blair et al. 2010. PubMed ID: 19965854; Yamamoto-Watanabe et al. 2010. PubMed ID: 20621307). This variant is reported in 0.0041% of alleles in individuals of African descent in gnomAD. This variant is interpreted as pathogenic. - |
Amyotrophic lateral sclerosis type 6 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 31, 2010 | - - |
Amyotrophic lateral sclerosis type 6;C3539195:Tremor, hereditary essential, 4 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 01, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 521 of the FUS protein (p.Arg521Cys). This variant is present in population databases (rs121909668, gnomAD 0.004%). This missense change has been observed in individual(s) with amyotrophic lateral sclerosis (PMID: 19251627, 19251628, 20598774, 20621307; Invitae). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 16224). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects FUS function (PMID: 19251628, 21487023). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts the p.Arg521 amino acid residue in FUS. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19251627, 20577002, 20668259, 22055719; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at